Pro-Dex, Inc.
NASDAQ:PDEXMedical - Instruments & Supplies
+$3.54 today
- Market cap
- $204.61M
- Beta
- -0.00
- P/E (TTM)
- 17.1
- EPS (TTM)
- $3.75
Volume 0.04M
Average 0.04M
PDEX Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Pro-Dex, Inc.NASDAQ: PDEX
Depreciation & Amortization · Q3 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q3 FY2026 depreciation & amortization of $363K rose 17.1% year over year, behind the +85.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 15.6% from the prior quarter. Over 3 fiscal years it compounded at +19.5% a year.
Context
- Depreciation & amortization amounted to 1.9% of revenue in FY2025, down 0.3 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +17.1% toward the trailing-twelve-month pace of +85.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.24M USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- +14.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 1.24M | +6.8% |
| FY2024 | 2024-06-30 | 1.16M | +35.4% |
| FY2023 | 2023-06-30 | 857K | +18.0% |
| FY2022 | 2022-06-30 | 726K | +0.0% |
| FY2021 | 2021-06-30 | 726K | — |
Depreciation & Amortization vs competitors
How PDEX compares with its peers on the latest reported figures
- PDEX's LTM Mar 2026 depreciation & amortization of $2.28M is the 2nd highest of the 9 companies compared; the peer median is $469K.
- Its year-over-year change of +85.2% is the highest of 9, against a peer median of -3.3%.
- Depreciation & amortization amounts to 3.1% of revenue for PDEX, versus a peer median of 13.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3.11M | -4.9% | +4.7% | 9.0% | |
| LTM Mar 2026 | $2.28M | +85.2% | +19.5% | 3.1% | |
| LTM Mar 2026 | $917K | +9.7% | +7.5% | 1608.8% | |
| LTM Mar 2026 | $873K | -1.6% | -23.3% | 17.0% | |
| LTM Mar 2026 | $687K | +18.4% | -9.7% | 1.2% | |
| LTM Mar 2026 | $251K | -0.8% | -1.0% | — | |
| LTM Mar 2026 | $44K | -43.6% | -22.8% | 41.9% | |
| LTM Mar 2026 | $23.95K | -96.6% | -41.3% | 6.0% | |
| LTM Mar 2026 | $876 | -75.7% | -21.0% | — | |
| Peer median (excluding PDEX) | $469K | -3.3% | -15.4% | 13.0% | |
Competitors are the stored peer set for PDEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 42.04M | 42.04M | 46.09M | 53.84M | 66.59M |
| Cost of Revenue | 28.91M | 28.91M | 33.34M | 39.29M | 47.08M |
| Gross Profit | 13.13M | 13.13M | 12.75M | 14.55M | 19.51M |
| Gross Margin | 31.2% | 31.2% | 27.7% | 27.0% | 29.3% |
| Research & Development | 2.98M | 2.98M | 2.8M | 3.19M | 3.64M |
| Selling, General & Admin | 4.99M | 4.99M | 4.18M | 4.19M | 5.19M |
| Operating Expenses | 8.01M | 8.01M | 6.99M | 7.38M | 8.82M |
| Depreciation & Amortization | 726K | 726K | 857K | 1.16M | 1.24M |
| EBITDA | 6.88M | 6.88M | 10.82M | 4.35M | 14.13M |
| EBITDA Margin | 16.4% | 16.4% | 23.5% | 8.1% | 21.2% |
| Operating Income | 5.12M | 5.12M | 5.76M | 7.17M | 10.69M |
| Operating Margin | 12.2% | 12.2% | 12.5% | 13.3% | 16.1% |
| Interest Income | 126K | 76K | 294K | 144K | 82K |
| Interest Expense | 352K | 464K | 533K | 558K | 829K |
| Other Income / Expenses | 571K | 571K | 3.67M | (4.54M) | 1.37M |
| Income Before Tax | 5.69M | 5.69M | 9.43M | 2.63M | 12.06M |
| Pre-Tax Margin | 13.5% | 13.5% | 20.5% | 4.9% | 18.1% |
| Income Tax Expense | 1.12M | 1.12M | 2.35M | 507K | 3.08M |
| Net Income | 4.57M | 4.57M | 7.07M | 2.13M | 8.98M |
| Net Margin | 10.9% | 10.9% | 15.3% | 4.0% | 13.5% |
| EPS (Basic) | 1.17 | 1.26 | 1.98 | 0.61 | 2.73 |
| EPS (Diluted) | 1.13 | 1.21 | 1.95 | 0.60 | 2.67 |
| Weighted Avg Shares | 3.8M | 3.64M | 3.57M | 3.5M | 3.29M |
| Weighted Avg Shares (Diluted) | 3.94M | 3.76M | 3.64M | 3.57M | 3.36M |
Pro-Dex, Inc.
NASDAQ:PDEX
Intrinsic Alpha fair value
Locked
Current Price
$63.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.